Manufacturing Considerations of mRNA- Based Therapeutics

Time: 12:15 pm
day: Day One

Details:

  • New API modalities require new manufacturing processes
  • The optimal mRNA processes may depend on the application – for example, a pandemic vaccine versus a personalized therapy
  • Fibro-based chromatography for large target molecules can boost productivity

Speakers: